Sweden’s USD 4.8 billion pharmaceutical market, its population size of 10 million and marginal positioning on the northerly fringe of the European…

Ayman Mokhtar is the general manager (GM) of GCC, Iraq and Iran for Upjohn, a Pfizer division. He spoke to us about his professional journey and…

Key stakeholders in Swedish pharma explain why Sweden's record on cancer care is the best in Europe and what more still needs to be done.…

Selim Sezgin, country manager and managing director of Pfizer Thailand, highlights the recent transformation of the affiliate to adapt to Thailand’s…

Giuseppe Allocca, Pfizer’s site leader for its Vega Baja & Barceloneta operations in Puerto Rico, highlights the importance of Pfizer’s…

Sweden, home of IKEA, Pippi Longstocking and Abba, is one of Europe's most innovative and forward-thinking nations in the healthcare and life sciences…

Malin Parkler, country manager of Pfizer Sweden, breaks down the extensive footprint of Pfizer in Sweden across the value chain, lays down the…

PharmaBoardroom last reported on Thailand in 2015, meeting country managers from across the healthcare and life sciences value chain. Here, we chart…

The top 50 most sold drugs in Sweden for 2018. AbbVie's Humira takes the top spot for the second year running, followed by Gilead's Epclusa and BMS…

Pfizer, in an attempt to bolster its oncology portfolio, is set to acquire Array Biopharma for USD 10.6 billion in the second half of 2019. The deal…

The Top 20 pharma companies in Sweden ranked by sales in 2018. Out in front is Swiss giant Novartis with approx USD 256 million in sales, followed by…

On May 30th, and with much fanfare, Pfizer Upjohn officially inaugurated its global headquarters in the heart of Shanghai, China. Following a global…